Litigation Details for DUKE UNIVERSITY v. APOTEX, INC. (M.D.N.C. 2014)
✉ Email this page to a colleague
DUKE UNIVERSITY v. APOTEX, INC. (M.D.N.C. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-12-09 |
| Court | District Court, M.D. North Carolina | Date Terminated | 2015-08-31 |
| Cause | 35:271 Patent Infringement | Assigned To | Catherine Caldwell Eagles |
| Jury Demand | Referred To | Lawrence Patrick Auld | |
| Parties | APOTEX, INC. | ||
| Patents | 8,906,962; 8,926,953 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in DUKE UNIVERSITY v. APOTEX, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for DUKE UNIVERSITY v. APOTEX, INC. (M.D.N.C. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-05-19 | 31 | by Defendants of United States Patent No. 8,906,962 (“the ‘962 patent”), held by Plaintiff Duke University…by Defendants of United States Patent No. 8,926,953 (the ‘953 patent), held by Plaintiff Allergan. …validity of the ‘962 patent, Plaintiffs appear to seek to withdraw that patent. Because Plaintiffs…mention the ‘962 patent and seeks dismissal only of claims concerning the ‘953 patent. (See Docket Entry…‘953 patent’s claims demonstrate substantial similarity to previously litigated patents invalidated | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
